Here’s whether Eli Lilly & Co. (LLY) is worth buying in 2026 —
based on weekly-updated price trend, RSI momentum, and return vs.
the S&P 500. Our current read: Bullish.
🟢
Bullish
Positives: trading above the 200-day MA (long-term uptrend intact); above the 50-day MA (medium-term momentum positive); 50-day MA is rising (+1.94% over 10 days); RSI 47 — healthy momentum range; strong 1-year return of +72.4%; 3-month momentum positive (+17.4%); rising volume confirms the move (1.19x 30d avg). Currently 5.5% off its 52-week high. Score: +8/7.
LLY is in a confirmed uptrend, trading above both its 50-day ($1,169.54) and 200-day ($1,043.22) moving averages. An RSI of 47.3 sits in the neutral zone — momentum is neither stretched nor exhausted. The 1-year return of +72.4% compares to +20.4% for SPY (beat the market by 52.1%).
$10,000 invested 1 year ago→ $17,243 today
vs. S&P 500 (SPY) — same period beat market by 52.1%
1-Year Price Chart
Daily candles
MA-50MA-200UpDown
Signal Check
✓Above 200-day MA ($1,043.22)
✓Above 50-day MA ($1,169.54)
✓RSI(14) neutral zone (30–70) — currently 47.3
✓Positive return (+72.4%)
✓Within 10% of period high (−5.5%)
Period Range $1,180.16
$655.10$1,249.45
RSI (14) 47.3
0 · OversoldOverbought · 100
Key Metrics
Price$1,180.16
Period Return+72.4%
Period High$1,249.45
Period Low$655.10
Drawdown−5.5%
MA-50$1,169.54
MA-200$1,043.22
RSI (14)47.3
Avg Volume (30d)2.6M
vs. SPYbeat by 52.1%
Return Rank#201 of 1252
Trend Signals
Price is above the 200-day moving average ($1,043.22)
Price is above the 50-day moving average ($1,169.54)